diarrhea after glp-1 Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus 🚨 Did you know that

The MHRA has issued repeated warnings about the serious risks of purchasing unlicensed medicines online, including receiving counterfeit or contaminated products and the absence of medical supervision

In obesity, SURMOUNT1 showed ~1521% mean weight loss at 72 weeks and headtohead data show greater loss than semaglutide in nondiabetic obesity

When the road youre trudging on seems all uphill

Can a genetic test guide weight-loss decisions

Recent Findings Preliminary data suggest that GLP-1 RA can modulate crucial pathways in the pathogenesis of IBD, such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity